Select a Region North America


Glenn Ravelo

Vice President, Oncology Key Accounts


Commercialization, Field Sales & Reimbursement, Launch Readiness, Leadership, Managed Care, Managed Markets, Market Access, Oncology, Pricing, Reimbursement & Market Access, Sales

Glenn brings more than 35 years of experience to EVERSANA’s team of experts who are addressing unique oncology challenges with agility and data-driven solutions. Throughout his career in executive-level roles, Glenn has become an expert in directing strategies and operations to expand market access for products. His leadership experience spans business development, sales, distribution and corporate accounts, allowing him to successfully integrate leadership and strategy to deliver value across pharma for manufacturers and patients.

Glenn holds a bachelor’s degree in biology from Spring Hill College (Mobile, AL) and a Master of Business Administration from Nova Southeastern University.

Articles by Glenn Ravelo

Next Gen Commercialization: Accelerating Patient Access to Life-Changing Therapies

Fifty years ago, only half of the patients diagnosed with cancer in the United States would have been alive five years later. By 2009, patient survival climbed to 70%. The problem is, in all our years working in the pharmaceutical industry and oncology, commercialization has not evolved with science. Manufacturers preparing for launch probably only see three options: sell their product to a big box pharmaceutical company, license or co-promote their product to a company with an established infrastructure, or launch internally with their own team. However, today’s unpredictable landscape, coupled with inevitable industry pressures, is forcing manufacturers to seek a more complete commercialization approach with less risk and more value. […]

Interested in scheduling a meeting or speaking event?


  • このフィールドは入力チェック用です。変更しないでください。